119 related articles for article (PubMed ID: 16868033)
1. Variability of CYP2J2 expression in human fetal tissues.
Gaedigk A; Baker DW; Totah RA; Gaedigk R; Pearce RE; Vyhlidal CA; Zeldin DC; Leeder JS
J Pharmacol Exp Ther; 2006 Nov; 319(2):523-32. PubMed ID: 16868033
[TBL] [Abstract][Full Text] [Related]
2. Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney.
Yu Z; Huse LM; Adler P; Graham L; Ma J; Zeldin DC; Kroetz DL
Mol Pharmacol; 2000 May; 57(5):1011-20. PubMed ID: 10779386
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.
Liu PY; Li YH; Chao TH; Wu HL; Lin LJ; Tsai LM; Chen JH
Atherosclerosis; 2007 Nov; 195(1):199-206. PubMed ID: 17126841
[TBL] [Abstract][Full Text] [Related]
4. Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2.
Spiecker M; Darius H; Hankeln T; Soufi M; Sattler AM; Schaefer JR; Node K; Börgel J; Mügge A; Lindpaintner K; Huesing A; Maisch B; Zeldin DC; Liao JK
Circulation; 2004 Oct; 110(15):2132-6. PubMed ID: 15466638
[TBL] [Abstract][Full Text] [Related]
5. Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues.
Delozier TC; Kissling GE; Coulter SJ; Dai D; Foley JF; Bradbury JA; Murphy E; Steenbergen C; Zeldin DC; Goldstein JA
Drug Metab Dispos; 2007 Apr; 35(4):682-8. PubMed ID: 17220242
[TBL] [Abstract][Full Text] [Related]
6. CYP2J2*7 single nucleotide polymorphism in a Chinese population.
Wang H; Jiang Y; Liu Y; Lin C; Cheng G; Chen X; Hao B; Tan W; Lin D; He F
Clin Chim Acta; 2006 Mar; 365(1-2):125-8. PubMed ID: 16182271
[TBL] [Abstract][Full Text] [Related]
7. Inter-individual variation of cytochrome P4502J2 expression and catalytic activities in liver microsomes from Japanese and Caucasian populations.
Yamazaki H; Okayama A; Imai N; Guengerich FP; Shimizu M
Xenobiotica; 2006 Dec; 36(12):1201-9. PubMed ID: 17162467
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of CYP2j2 gene and protein in
Kamel S; Ibrahim M; Awad ET; El-Hindi HMA; Abdel-Aziz SA
J Biol Regul Homeost Agents; 2018 NOV-DEC; 32(6):1473-1477. PubMed ID: 30378391
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart.
Wu S; Moomaw CR; Tomer KB; Falck JR; Zeldin DC
J Biol Chem; 1996 Feb; 271(7):3460-8. PubMed ID: 8631948
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.
Xu M; Ju W; Hao H; Wang G; Li P
Drug Metab Rev; 2013 Aug; 45(3):311-52. PubMed ID: 23865864
[TBL] [Abstract][Full Text] [Related]
11. Promoter polymorphism G-50T of a human CYP2J2 epoxygenase gene is associated with common susceptibility to asthma.
Polonikov AV; Ivanov VP; Solodilova MA; Khoroshaya IV; Kozhuhov MA; Panfilov VI
Chest; 2007 Jul; 132(1):120-6. PubMed ID: 17475630
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension.
King LM; Gainer JV; David GL; Dai D; Goldstein JA; Brown NJ; Zeldin DC
Pharmacogenet Genomics; 2005 Jan; 15(1):7-13. PubMed ID: 15864120
[TBL] [Abstract][Full Text] [Related]
13. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of cardiac L-type Ca2+ currents in transgenic mice with cardiac-specific overexpression of CYP2J2.
Xiao YF; Ke Q; Seubert JM; Bradbury JA; Graves J; Degraff LM; Falck JR; Krausz K; Gelboin HV; Morgan JP; Zeldin DC
Mol Pharmacol; 2004 Dec; 66(6):1607-16. PubMed ID: 15361551
[TBL] [Abstract][Full Text] [Related]
15. CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ.
Li R; Xu X; Chen C; Wang Y; Gruzdev A; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Feb; 308(4):E270-82. PubMed ID: 25389363
[TBL] [Abstract][Full Text] [Related]
16. Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes.
Aliwarga T; Evangelista EA; Sotoodehnia N; Lemaitre RN; Totah RA
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966295
[TBL] [Abstract][Full Text] [Related]
17. Cloning of CYP2J2 gene and identification of functional polymorphisms.
King LM; Ma J; Srettabunjong S; Graves J; Bradbury JA; Li L; Spiecker M; Liao JK; Mohrenweiser H; Zeldin DC
Mol Pharmacol; 2002 Apr; 61(4):840-52. PubMed ID: 11901223
[TBL] [Abstract][Full Text] [Related]
18. Expression of cytochrome P450 arachidonic acid epoxygenase 2J2 in human tumor tissues and cell lines.
Jiang JG; Fu XN; Chen CL; Wang DW
Ai Zheng; 2009 Feb; 28(2):93-6. PubMed ID: 19550113
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of human CYP2J2 in HepG2 cells by butylated hydroxyanisole is mediated by c-Jun and Nrf2.
Lee AC; Murray M
Mol Pharmacol; 2010 Jun; 77(6):987-94. PubMed ID: 20194533
[TBL] [Abstract][Full Text] [Related]
20. Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes.
Nakayama K; Nitto T; Inoue T; Node K
Life Sci; 2008 Aug; 83(9-10):339-45. PubMed ID: 18675280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
